Curaleaf Holdings (CURLF) Share-based Compensation (IS) (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly Share-based Compensation (IS) of $9.7 million in Q1 2026, down 6.12% quarter-over-quarter from $10.3 million in Q3 2025, and up 109.0% on a YoY basis from $4.6 million in Q1 2025.
Curaleaf Holdings (CURLF) Share-based Compensation (IS) (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Share-based Compensation (IS) history runs 8 years deep, the most recent figure standing at $9.7 million for Q1 2026.
- In Q1 2026, Share-based Compensation (IS) rose 109.0% year-over-year to $9.7 million; the TTM figure through Mar 2026 stood at $33.1 million (up 32.27% YoY), while the FY2022 annual figure was $6.9 million, down 82.54% from the prior year.
- Share-based Compensation (IS) was $9.7 million for Q1 2026 at Curaleaf Holdings, down from $10.3 million in the prior quarter.
- In the past five years, Share-based Compensation (IS) ranged from a high of $10.3 million in Q3 2025 to a low of $4.6 million in Q1 2025.
- Historically, Share-based Compensation (IS) has averaged $7.0 million across 5 years, with a median of $6.8 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Share-based Compensation (IS) plunged 60.58% in 2022, then jumped 109.0% in 2026.
- A 5-year view of Share-based Compensation (IS) shows it stood at $6.9 million in 2022, then slipped by 9.72% to $6.2 million in 2023, then decreased by 3.29% to $6.0 million in 2024, then surged by 71.08% to $10.3 million in 2025, then retreated by 6.12% to $9.7 million in 2026.
- The last three Share-based Compensation (IS) figures came in at $9.7 million (Q1 2026), $10.3 million (Q3 2025), and $8.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | 9.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.66 Mn |
| Mar 31, 2026 | 9.66 Mn |
| Sep 30, 2025 | 10.29 Mn |
| Sep 30, 2025 | 10.29 Mn |
| Jun 30, 2025 | 8.48 Mn |
| Jun 30, 2025 | 8.48 Mn |
| Mar 31, 2025 | 4.62 Mn |
| Mar 31, 2025 | 4.62 Mn |
| Sep 30, 2024 | 6.02 Mn |
| Sep 30, 2024 | 6.02 Mn |
| Jun 30, 2024 | 6.84 Mn |
| Jun 30, 2024 | 6.84 Mn |
| Mar 31, 2024 | 7.51 Mn |
| Mar 31, 2024 | 7.51 Mn |
| Sep 30, 2023 | 6.22 Mn |
| Sep 30, 2023 | 6.22 Mn |
| Jun 30, 2023 | 6.25 Mn |
| Jun 30, 2023 | 6.25 Mn |
| Dec 31, 2022 | 6.89 Mn |
| Dec 31, 2022 | 6.89 Mn |